Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions

Journal of Lower Genital Tract Disease

Volumn 11, Issue 2, 2007, Pages 98-104

  Focchi, Gustavo R A ^a   Silva, Ismael D C G ^a   Nogueira De Souza, Naiara C ^a   Dobo, Cristine ^a   Oshima, Celina T ^a   Stavale, João N ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Immunohistochemistry; p16

Indexed keywords

PROTEIN P16;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORPHOLOGY; OUTCOME ASSESSMENT; PREDICTION; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; UTERINE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; VIRUS DETECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; EPITHELIAL CELLS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 34247177493     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.lgt.0000245042.29847.dd     Document Type: Article

References (37)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature 2002;2:342-50.
2. Walboomers JMM, Jacobs MV, Manos MM, Xavier Bosch F, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
3. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
4. INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
5. Pientong C, Ekalaksananan T, Kongingyoes B, Kritpetcharat O, Swadpanich U, Pengsa P, et al. Immunocytochemical staining of p16INK4A protein from conventional Pap test and its association with human papillomavirus infection. Diagn Cytopathol 2004;31:235-42.
6. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations. Realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-5.
7. Heatley MK, Wilson GE, Ismail SM, Fiander AN. Expert opinion: how should we grade CIN? Histopathology 2002;40:377-90.
8. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, et al. Ki-67, cyclin E and p16 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91.
9. INK4a Immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-99.
10. Mount SL, Evans MF, Wong C, Cooper K. Human papillomavirus-induced lesions of the cervix. A review and update on the grading of cervical dysplasia. Pathol Case Rev 2003;8:145-51.
11. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002;38:2229-42.
12. Tam SW, Shay JW, Pagano M. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16INK4. Cancer Res 1994;54:5816-20.
13. Cotran R, Kumar V, Robbins SL. Neoplasia. In: Cotran R, Kumar V, Robbins SL, eds. Robbins Basic Pathology, 7th ed. New York: Elsevier Saunders, 2003:182-6.
14. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998;48:580-5.
15. Tsuda H, Hashiguchi Y, Nishimura S, Kawamura N, Inoue T, Yamamoto K. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm. Gynecol Oncol 2003;91:476-85.
16. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998;153:1741-8.
17. Keating JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol 2001;8:83-92.
18. Sano T, Masuda N, Oyama T, Nakajima T. Overexpression of p16 and p14 ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002;52:375-83.
19. INK4A in liquid-based specimens (SurePath™) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol 2002;27:365-70.
20. INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003;16:665-73.
21. Ishikawa M, Fujii T, Masumoto N, Saito M, Mukai M, Nindl I, et al. Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int J Gynecol Pathol 2003;22:378-85.
22. McCluggage WG, Jenkins D. p16 immunoreactivity may assist in the distinction between endometrial and endocervical carcinoma. Int J Gynecol Pathol 2003;22:231-5.
23. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, et al. P16 INK 4A as a marker for cervical dyskariosis. CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003;56:56-63.
24. Negri G, Vittadello F, Romano F, Kasal A, Rivasi F, Girlando S, et al. p16INK4A expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004;445:616-20.
25. Sahebali S, Depuydt CE, Segers K, Moeneclaey LM, Vereecken AJ, Van Marck E, et al. P16INK4A as an adjunct marker in liquid-based cytology. Int J Cancer 2004;108:871-6.
26. Schorge JO, Lea JS, Elias KJ, Rajanbabu R, Coleman R, Miller DS, et al. P16 as a molecular biomarker of cervical adenocarcinoma. Am J Obstet Gynecol 2004;190:668-73.
27. Tringler B, Gup CJ, Singh M, Groshong S, Shroyer AL, Heinz DE, et al. Evaluation of p16 INK4A and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004;35:689-96.
28. Trunk MJ, Dallenbach-Hellweg G, Ridder R, Petry KU, Ikenberg H, Schneider V, et al. Morphologic characteristics of p16INK4A-positive cells in cervical cytology samples. Acta Cytol 2004;48:771-82.
29. Klussmann JP, Gultekin E,Weissenborn SJ, Wieland U, Dries V, Dienes HP, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003;162:747-53.
30. Lu DW, El-Mofty SK, Wang HL. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod Pathol 2003;16:692-9.
31. Riethdorf S, Neffen EF, Cviko A, Loning T, Crum CP, Riethdorf L. p16 expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004;35:1477-83.
32. Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004;8:160-7.
33. Elishaev E, Gilks CB, Miller D, Srodon M, Kurman RJ, Ronnett BM. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Am J Surg Pathol 2005;29:281-94.
34. Guo M, Hu L, Baliga M, He Z, Hughson MD. The predictive value of p16 INK4A and Hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 2004;122:894-901.
35. Yoshida T, Fukuda T, Sano T, Kanuma T, Owada N, Nakajima T. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Cancer 2004;102:100-8.
36. Longatto Filho A, Utagawa ML, Shirata NK, Pereira SMM, Namiyama GM, Kanamura CT, et al. Immunocytochemical expression of p16 INK4A and ki-67 in cytologically negative and equivocal Pap smears positive for oncogenic human papillomavirus. Int J Gynecol Pathol 2005;24:118-24.
37. Nielsen GP, Stemmer-Rachamimov AO, Shaw J, Roy JE, Koh J, Louis DN. Immunohistochemical survey of p16INK4a expression in normal human adult and infant tissues. Lab Invest 1999;79:1137-42.